Author Correction: Serum GFAP as a biomarker for disease severity in multiple sclerosis

A Abdelhak; A Huss; J Kassubek; H Tumani; M Otto

doi:10.1038/s41598-019-43990-1

Author Correction: Serum GFAP as a biomarker for disease severity in multiple sclerosis

Sci Rep. 2019 Jun 5;9(1):8433. doi: 10.1038/s41598-019-43990-1.

Authors

A Abdelhak¹, A Huss², J Kassubek¹, H Tumani^{1

3}, M Otto⁴

Affiliations

¹ Department of Neurology, University Hospital of Ulm, Ulm, Germany.
² Department of Experimental Neurology, University of Ulm, Ulm, Germany.
³ Speciality Clinic of Neurology Dietenbronn, Schwendi, Germany.
⁴ Department of Neurology, University Hospital of Ulm, Ulm, Germany. markus.otto@uni-ulm.de.

Abstract

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.

Publication types

Published Erratum